Jynarque
Ended Awarded Last action
- Contract number
- 36C26024F0034
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $362,719
Award facts
- Contract value 100% obligated
- $362,719.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $37,763 | |
| Funding Only Action | $7,367 | |
| Original award | $317,589 |
About this award
Otsuka America Pharmaceutical Inc. received a $362,719.21 firm fixed price delivery order from Veterans Integrated Service Network (VISN) 20 for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This delivery order, awarded on October 1, 2023, with an ultimate completion date of September 30, 2024, was issued without a set-aside designation and will be performed in Pittsburgh, PA. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), through which the Department of Veterans Affairs procures specialized medications for veterans across its integrated service networks.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle with the VA, which includes an $83.3 million Blanket Purchase Agreement for Jynarque and a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. These agreements enable the VA to efficiently procure critical pharmaceutical treatments across multiple Veterans Integrated Service Networks nationwide, supporting the department's mission to provide comprehensive healthcare services to veterans requiring specialized pharmaceutical interventions.
Quick answers
Who was awarded contract 36C26024F0034?
36C26024F0034 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26024F0034 worth?
The government has obligated $362,719 on 36C26024F0034.
Is contract 36C26024F0034 an order under another contract?
Yes. 36C26024F0034 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0034 competed?
The extent of competition for 36C26024F0034 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award